Wilms Tumor

Wilms’ tumor, also known as nephroblastoma, is a specific type of cancer that begins in the kidneys and primarily in children. This is the most common type of kidney cancer found in children. Treatment options provide good prognosis for this disease. Discover the latest research on Wilms’ tumor here.

December 7, 2021

Body Region-Specific 3D Age-Scaling Functions for Scaling Whole-Body Computed Tomography Anatomy for Pediatric Late Effects Studies.

Biomedical Physics & Engineering Express
Aashish Chandra GuptaRebecca M Howell
December 7, 2021

In vitro effects of cannabidiol and its main metabolites in mouse and human Sertoli cells.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Yuxi LiSi Chen
December 6, 2021
Open Access

The Association of Nephroblastoma Overexpressed (NOV) and Endothelial Progenitor Cells with Oxidative Stress in Obstructive Sleep Apnea.

Oxidative Medicine and Cellular Longevity
Eddie W FakhouriStephen J Peterson
December 6, 2021
Open Access

METTL14 gene polymorphisms decrease Wilms tumor susceptibility in Chinese children.

BMC Cancer
Zhenjian ZhuoJing He
December 4, 2021

MiR-155-5p affects Wilms' tumor cell proliferation and apoptosis via targeting CREB1.

European Review for Medical and Pharmacological Sciences
X-S ZhaoC-Y Dong
December 4, 2021

Tumor-Related Molecular Regulatory Mechanisms of Long Non-Coding RNA RMST: Recent Evidence.

Mini Reviews in Medicinal Chemistry
Xuhui ChenChengfu Yuan
December 3, 2021

Prevalence of hearing screening failures in low-risk childhood cancer survivors.

Pediatric Blood & Cancer
Meghan PhelanRobert J Hayashi
December 2, 2021

Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients.

Journal of Cancer Research and Therapeutics
Xiangyu WuWei Liu
December 1, 2021
Open Access

Whole exome sequencing identified a rare WT1 loss-of-function variant in a non-syndromic POI patient.

Molecular Genetics & Genomic Medicine
Yingchen WangXiaojin Zhang
November 30, 2021
Case Report

Primary Renal Synovial Sarcoma Case Series: Clinical Profile and Management of a Rare Entity.

Urologia Internationalis
Anand RajaArun R Menon
November 26, 2021
Open Access

Knockdown of SENP1 inhibits HIF-1α SUMOylation and suppresses oncogenic CCNE1 in Wilms tumor.

Molecular Therapy Oncolytics
Shibo ZhuWei Jia
November 26, 2021

Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors.

JCO Precision Oncology
Lieke M J van ZogchelGodelieve A M Tytgat
November 26, 2021

Identification of Pax protein inhibitors that suppress target gene expression and cancer cell proliferation.

Cell Chemical Biology
Shayna T J BradfordGregory R Dressler
November 23, 2021

Postchemotherapy tumor volume as a prognostic indicator in Wilms tumor: A single-center experience from South India.

Pediatric Blood & Cancer
Leenu Lizbeth JosephSidharth Totadri

Sign up to follow this feed and discover related papers.

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Hamartoma Syndrome, Multiple

Multiple Hamartoma Syndrome, also known as Cowden disease, is a hereditary autosomal dominant condition associated with mutations in tumor suppressor PTEN. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Hereditary Cancer Syndromes

Hereditary cancer syndromes comprise 5% of all cancers and have an increased risk of early onset and of multiple or bilateral malignancies. Here is the latest research on hereditary cancer syndromes.

Hereditary Nonpolyposis Colorectal Neoplasms

Hereditary Nonpolyposis Colorectal Neoplasms are a type of inherited autosomal dominant colon cancer and is associated with mutations in mismatch repair genes. Discover the latest research on Hereditary Nonpolyposis Colorectal Neoplasms.

Li-Fraumeni Syndrome

Li-Fraumeni syndrome in an inherited predisposition to a range of cancers due to a mutation in the tumor suppressor gene TP53. The diagnosis is made if cancer occurs at a young age and there is also a family history of sarcoma or cancer at a young age. Find the latest research on Li-Fraumeni syndrome here.

Multiple Endocrine Neoplasia

Multiple Endocrine Neoplasia is a group of inherited autosomal dominant cancers that occur in multiple hormone producing grandular organs. Discover the latest research on Multiple Endocrine Neoplasia here.


Neurofibromatosis is a genetic disorder that causes tumors to form in the central nervous system. While these tumors are typically benign, they can become malignant. Other complications of neurofibromatosis include hearing loss, learning impairment, vision loss, etc. Here is the latest research.

Neurofibromatosis 1

Neurofibromatosis 1 (NF1), also known as von Recklinghausen disease, is an autosomal dominant condition caused by mutations in the NF1 gene. Here is the latest research.

Neurofibromatosis 2

Type 2 Neurofibromatosis are rare inherited autosomal dominant diseases caused by the NF2 gene. It is characterized by the growth of noncancerous tumors in the nervous system, specifically along the auditory nerve. Symptoms include hearing loss, tinnitus, and balance problems. Here is the latest research on Type 2 Neurofibromatosis.

© 2021 Meta ULC. All rights reserved